Performing a task better while receiving a drug does not establish that the improvement will persist after the drug is withdrawn. A 1966 experiment by Schuster, Dockens and Woods tested that question directly in four rats selected for relatively poor avoidance performance.
The investigators found sustained effects during daily amphetamine administration, but no lasting improvement when animals returned to saline conditions. The result separates persistence of an on-drug effect from transfer of better performance into the drug-free state.
Which animals and task were studied?
The avoidance experiment involved four Sprague-Dawley rats weighing approximately 350–375 g. After 125 hours of training, they were selected from a larger group because their avoidance performance was poor but stable. That selection is part of the study’s meaning: these were not four randomly chosen representatives of all possible baseline performers.
During daily ninety-minute sessions, a lever press postponed shock. If thirty seconds passed without a response, shock began and continued until a lever press or a maximum of ten seconds. There was no external warning signal immediately before shock.
The investigators recorded lever responses, shocks and escape latency. Responding to postpone a shock and responding to terminate one already underway were therefore distinguishable outcomes.
What amphetamine regimen was used?
After seven saline control sessions, the rats received 1.0 mg/kg d-amphetamine subcutaneously thirty minutes before each daily session for thirty-five days. The same administered dose was maintained during this first chronic treatment period.
The animals then completed twenty saline control sessions. Two of the four subsequently underwent a second twenty-day drug period that began at 1.0 mg/kg, with the dose reduced by 0.05 mg/kg each day. Seven further saline sessions followed that second period.
The tapering observations thus came from two animals, not the full group of four. The experiment did not measure blood amphetamine concentrations, so the administered mg/kg doses should not be converted into concentration thresholds.
Did every animal show the same improvement?
The total number of lever responses increased in all four animals throughout the initial chronic-drug regimen. Three animals—AV-1, AV-4 and AV-5—showed a marked reduction in shocks. The fourth, AV-2, showed a smaller increase in responding and no clear reduction in shocks.
That exception prevents an overly broad claim that increased responding necessarily improved avoidance to the same degree in every subject. A response count and its consequence are different measurements.
The approximately 0.6-second escape latencies were not changed by the drug regimen. Thus, even where the animals received fewer shocks, the paper did not demonstrate a general improvement in every speed-related endpoint.
Did the on-drug effect fade with repeated administration?
The increased response counts and the reduced shock frequency in the three responding animals showed no tendency to diminish across the thirty-five-day regimen. For these specific outcomes at this dose, the authors did not observe development of behavioral tolerance.
That description has a limited scope. It does not show absence of adaptation in every physiological system, absence of dependence, or an unchanged response to every amphetamine effect. No such comprehensive set of endpoints was measured.
The same paper examined food-reinforced behavior under different schedules and discussed different tolerance patterns. Its broader argument was that the relationship between behavior and its consequences could matter, rather than that an animal has one universal tolerance status.
What happened when amphetamine was withdrawn?
When the four rats returned to saline conditions after the first regimen, their performance immediately returned to the earlier pattern. Prolonged experience making more responses and avoiding more shocks had not produced a lasting improvement detectable under the study’s saline conditions.
In the two-animal tapering phase, response counts declined and shocks increased as the dose diminished. Their later saline performance again showed no improvement over the earlier saline baseline. The authors therefore did not find transfer of the facilitated avoidance performance after either abrupt withdrawal or gradual dose reduction in the tested animals.
The result concerns these observed task outcomes. It is not proof that the animals learned nothing during treatment, that no latent memory existed, or that a particular psychological mechanism uniquely caused the return to baseline.
How strong is the evidence for a general rule?
This is small, historical primary animal research, with repeated observations within individual subjects. The four-rat avoidance cohort and two-rat tapering subset are important limits. The findings should not be presented as a population estimate for the probability of transfer after stimulant treatment.
The protocol also selected poor baseline performers and used a specific shock-avoidance contingency. Results could depend on baseline proficiency, dose, task demands, consequences and the conditions under which transfer was assessed. The study did not experimentally isolate each of those possibilities.
The investigators proposed a working hypothesis about reinforcement conditions and behavioral tolerance. That proposal was an interpretation of preliminary experiments, not an independently validated explanation for every instance of amphetamine tolerance.
What can be carried into a human evidence review?
The useful distinction is between an effect maintained during exposure and a skill or behavioral improvement retained after exposure ends. Evidence for the first does not automatically establish the second.
This rat experiment cannot determine whether a human treatment improves long-term functioning, whether a person was impaired at a particular event, or how performance would change after a particular human withdrawal schedule. It does support asking a concrete question whenever a study is cited as evidence of durable improvement: was the claimed benefit actually tested after the drug was removed, and did it remain?
References
Schuster CR, Dockens WS, Woods JH. Behavioral variables affecting the development of amphetamine tolerance. Psychopharmacologia. 1966;9(2):170–182. doi:10.1007/BF00404721. Historical primary animal research; this commentary focuses on the four-rat avoidance experiment.
Leave a Reply